TIBER CREEK HEALTH STRATEGIES, INC.

Lobbying for GENENTECH, INC. · Biotechnology.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $60,000.00 income · posted Apr 17, 2025

Lobbying activity 1

Health Issues

Issues related to the 340b program - Public Health Service Act (P.L. 78-410); Issues related to PBM reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.